AbbVie Newsroom

Alector Downgraded to Underperform at BofA After Alzheimer's Trial Miss

Seeking Alpha01:26

AbbVie Analyst Ratings

BenzingaNov 22 20:45

Leerink Partners Upgrades AbbVie(ABBV.US) to Buy Rating, Announces Target Price $206

Futu NewsNov 22 19:31

Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $195

Futu NewsNov 19 16:38

Wells Fargo Adjusts Price Target on AbbVie to $195 From $205, Maintains Overweight Rating

MT NewswiresNov 18 23:46

Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating

MT NewswiresNov 16 01:44

Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205

Futu NewsNov 15 05:31

AbbVie Analyst Ratings

BenzingaNov 13 22:57

J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $200

Futu NewsNov 13 20:32

JPMorgan Adjusts Price Target on AbbVie to $200 From $210, Keeps Overweight Rating

MT NewswiresNov 13 20:08

UBS downgraded AbbVie's target price to $224.

Gelonghui FinanceNov 13 16:10

AbbVie Hold Rating Maintained Amid Emraclidine Trial Challenges and Competitive Pressure

TipRanksNov 13 15:11

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181

Futu NewsNov 13 03:32

AbbVie Is Maintained at Buy by Citigroup

Dow JonesNov 13 03:08

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $208

Futu NewsNov 12 22:35

AbbVie Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 12 21:39

AbbVie Analyst Ratings

BenzingaNov 12 21:31

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $224

Futu NewsNov 12 19:35

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $215

Futu NewsNov 12 19:35

AbbVie Buy Rating Affirmed Despite Emraclidine Setback, Driven by Skyrizi and Rinvoq Growth

TipRanksNov 12 19:13